Bulk and single-cell RNA-seq of iPSC-derived dopamine neurons from control and PD GBA-N370S patients stratified a clinically distinct patient and revealed HDAC4 as a potential therapeutic PD target. This evidence concerns the gene HDAC4 and Parkinson disease.